Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol
Richard Haynes, Colin Baigent, Paul Harden, Martin Landray…Том:
2
Мова:
english
DOI:
10.1186/2047-1440-2-7
Date:
December, 2013
Файл:
PDF, 359 KB
english, 2013